DK0558751T3 - Terapeutiske midler til behandling af sår - Google Patents

Terapeutiske midler til behandling af sår

Info

Publication number
DK0558751T3
DK0558751T3 DK91919800T DK91919800T DK0558751T3 DK 0558751 T3 DK0558751 T3 DK 0558751T3 DK 91919800 T DK91919800 T DK 91919800T DK 91919800 T DK91919800 T DK 91919800T DK 0558751 T3 DK0558751 T3 DK 0558751T3
Authority
DK
Denmark
Prior art keywords
agent
wounds
treatment
skin
therapeutic agents
Prior art date
Application number
DK91919800T
Other languages
Danish (da)
English (en)
Inventor
Hiroshi Nakao
Takao Nagoya
Yushi Saino
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of DK0558751T3 publication Critical patent/DK0558751T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91919800T 1990-11-20 1991-11-19 Terapeutiske midler til behandling af sår DK0558751T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31464890 1990-11-20
PCT/JP1991/001587 WO1992008475A1 (fr) 1990-11-20 1991-11-19 Agent therapeutique pour la peau ou contre les maladies corneennes

Publications (1)

Publication Number Publication Date
DK0558751T3 true DK0558751T3 (da) 2000-05-08

Family

ID=18055860

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919800T DK0558751T3 (da) 1990-11-20 1991-11-19 Terapeutiske midler til behandling af sår

Country Status (11)

Country Link
US (1) US5360789A (ko)
EP (1) EP0558751B1 (ko)
JP (1) JP3126733B2 (ko)
KR (1) KR100191192B1 (ko)
AT (1) ATE189393T1 (ko)
CA (1) CA2096520C (ko)
DE (1) DE69131964T2 (ko)
DK (1) DK0558751T3 (ko)
ES (1) ES2143467T3 (ko)
GR (1) GR3033157T3 (ko)
WO (1) WO1992008475A1 (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ533467A (en) 1993-07-19 2006-02-24 Angiotech Pharm Inc Anti-angiogenic compositions and methods of use
US20030203976A1 (en) * 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
JPH0848634A (ja) * 1994-08-05 1996-02-20 Akio Okamoto 角膜治療剤
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
AU7776701A (en) 2000-08-10 2002-02-25 Santen Pharmaceutical Co Ltd Skin wound healing promoters
US7635676B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7645739B2 (en) * 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US20090291086A1 (en) * 2001-02-21 2009-11-26 Alavita Pharmaceuticals, Inc. Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
EP1839670A3 (en) * 2001-02-21 2009-11-11 Alavita Pharmaceuticals, Inc. Modified Annexin Proteins and their use against thrombosis
US20050222030A1 (en) * 2001-02-21 2005-10-06 Anthony Allison Modified annexin proteins and methods for preventing thrombosis
US7635680B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
CA2439100A1 (en) * 2001-02-26 2002-09-06 Kowa Company, Ltd. Eye drop
AU2003903896A0 (en) * 2003-07-28 2003-08-07 Queensland University Of Technology Skin regeneration system
EP2268299B1 (en) 2008-04-01 2013-07-17 MosaMedix B.V. Compositions for reducing scar formation in wound healing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1265446A (en) * 1985-09-30 1990-02-06 Masahiro Maki Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component
JPH0764878B2 (ja) * 1986-10-14 1995-07-12 興和株式会社 抗血液凝固物質及びその製法
US4937324A (en) * 1987-02-06 1990-06-26 Zymogenetics, Inc. Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity
JP2660514B2 (ja) * 1987-02-20 1997-10-08 興和株式会社 抗血液凝固作用を有するポリペプチド
JPH06799B2 (ja) * 1987-04-02 1994-01-05 帝人株式会社 起炎性フオスフオリパ−ゼａ▲下２▼阻害活性を有する蛋白
ES2096556T3 (es) * 1988-02-26 1997-03-16 Biogen Inc Secuencias de adn, moleculas de adn recombinante y procedimientos para producir lipocortinas iii, iv, v y vi.
US5179081A (en) * 1988-07-21 1993-01-12 Kowa Co., Ltd. Method of treatment using an anticoagulant polypeptide

Also Published As

Publication number Publication date
CA2096520A1 (en) 1992-05-21
JP3126733B2 (ja) 2001-01-22
DE69131964T2 (de) 2000-05-18
WO1992008475A1 (fr) 1992-05-29
KR930702019A (ko) 1993-09-08
EP0558751B1 (en) 2000-02-02
GR3033157T3 (en) 2000-08-31
ATE189393T1 (de) 2000-02-15
KR100191192B1 (ko) 1999-06-15
EP0558751A4 (en) 1994-07-13
US5360789A (en) 1994-11-01
ES2143467T3 (es) 2000-05-16
CA2096520C (en) 2000-12-19
EP0558751A1 (en) 1993-09-08
DE69131964D1 (de) 2000-03-09

Similar Documents

Publication Publication Date Title
DK0558751T3 (da) Terapeutiske midler til behandling af sår
NO880719L (no) Polypeptid, dna og anvendelse derav.
ES2191068T3 (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
DK357386D0 (da) Saarhelende midler
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
DE69535976D1 (de) Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor
SE9300683L (sv) Ytmaterial för absorberande artiklar
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
DK71387A (da) Terapeutisk middel til behandling af psoriasis
SE9701161D0 (sv) New use I
ES2196027T3 (es) Tratamiento de enfermedades vasculares degenerativas mediante modulacion de la produccion o actividad del oxido nitrico exogeno.
IT1240683B (it) Composizione farmaceutica contenente egf
ATE113209T1 (de) Verwendung von 5-amino-salicylsäure für die behandlung von hautkrankheiten.
ES2175006T3 (es) N-(pirimidinil)-benzosulfonamidas como medicamentos.
MY107235A (en) Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase.
DE69943240D1 (de) Verwendung von HGF für die Behandlung von ischämischen Erkrankungen der Extremitäten
FR2694694B1 (fr) Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu.
DK0673646T3 (da) Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme
DE69330809D1 (de) Therapeutisches Agens für Neutropenie
DE69206665D1 (de) Mittel zur topischen Behandlung von Verbrennungen
Demidov et al. Helium-neon laser in prophylaxis of suppuration and treatment of operative purulent wounds in tuberculous patients.